Drug Reports
These describe a drug’s journey through the R&D process. Records
are continuously updated as new information is published. Comments from experts
are also added in the form of literature evaluations, providing a professional
opinion about the significance of a drug.
Drug reports contain all the specific compound information you need. The data
is searchable and you can drill down to the underlying reference reports. You
also can link to news and company reports and access key patent information.
A typical drug report will include:
Drug Overview - at the top of the report there is a table providing
a quick overview of the drug. This also includes an easy to use "e-mail if updated"
function that enables you to receive an alert immediately after a particular
drug report is updated.
Full Text Summary - for users requiring further information the drug
report also includes a full text summary providing detailed information on the
drug company, chemical structure, development status and licensing arrangements.
Literature Evaluation - a comprehensive literature evaluation with
links to the full reports. Typical areas reviewed include: clinical trials,
pharmacology, side effects, synthesis, toxicity and a current opinion written
by an expert in this particular field.
Scientific Data - Clinical, Chemical Metabolism and Biological study
reports are summarized in this section. Simply click on the link to go to the
report of interest.
Company Reports
You can access everything you need to know about a company via dynamic company
reports. They contain comprehensive fielded company profiles and include information
on licensing agreements, financial data, and graphs summarizing each company’s
R&D portfolio.
Links from the R & D product portfolio graphs to the underlying drug and patent
reports provide a quick and easy overview of a competitor's R & D activities.
A company's product portfolio is analyised in three easy to use charts:
- Investigational drugs by therapeutic category
- Patents by therapeutic category
- Drugs by stage of development
Patent Reports
Patents from five of the world’s major issuing authorities are screened
and summarized in weekly-updated patent reports. Fully linked and structure
searchable, our unique patent reports allow you to locate further underlying
information on the company.
Reports are generally available within two to three weeks of publication and
you can link to the full text of the original patent. Lists of new patents are
viewable each week.
IDdb's superior patent coverage alerts researchers to potential competitor
compounds and provides a complete picture of competitors' early research portfolios.
Additionally, the IDdb Portal provides links to the full text of the
original patent information via the MicroPatent Internet site.
- Patent information is also available in Thomson Current Drugs' weekly patent
monitoring service, Patent fast alert.
Meeting Reports
Through coverage of more than 300 key scientific and pharma-business related
meetings per year, you can remain fully informed of the latest developments
in your field of interest.
Information is broken down into topic areas, making it easy to quickly find
sections of interest.
A full list of references is provdied, linking back to any relevant information
that may be available within IDdb.
Reference Reports & Bibliographies
Reference reports are available in either full text or summary versions. Consolidated
within both company and drug bibliographies, these reports frequently contain
informative and invaluable expert comment and opinion.
Company and Drug Bibliographies
To enable an investigator to obtain all references to any particular company or
drug, a full list can be found in this single report. It can be sorted by author,
date, or type of report, making it easier to find the information you want.
Simply select the reference you wish to view and click to show the full report.
